CONTROL OF HL-60 CELL-DIFFERENTIATION LINEAGE SPECIFICITY, A LATE EVENT OCCURRING AFTER PRECOMMITMENT
- 1 January 1987
- journal article
- research article
- Vol. 47 (1) , 129-134
Abstract
Terminal cell differentiation of HL-60 promyelocytic leukemia cells results when they are continuously exposed to retinoic acid. This process involves an intermediate regulatory state, the precommitment memory state, which occurs before onset of differentiation or growth arrest in G0. The cellular processes occurring prior to onset of terminal differentiation can be resolved into early events anteceding development of the precommitment memory state and late events subsequent to it. While it has been suggested that retinoic acid induced early events regulate G1/0 specific growth arrest associated with terminal differentiation, the significance of induced late events is not known. Exploiting the capability of HL-60 cells to undergo either myeloid or monocytic differentiation in response to different inducers, the present studies examine the response of HL-60 cells to the sequential application of myeloid and monocytic inducers prior to onset of terminal differentiation. The results indicate that the precommitment state induced by retinoic acid is not differentiation lineage specific. Sequential application first of retinoic acid, a myeloid inducer, and then of 1,25-dihydroxyvitamin D3, a monocytic inducer, and vice versa, show that cellular choice of a specific differentiation lineage is regulated by late inducer driven events. The data support a two-step model for induction of terminal differentiation where early events anteceding precommitment regulate growth arrest and late events subsequent to precommitment regulate choice of a specific differentiation lineage. The results are of potential significance to the use of differentiation-inducing agents in chemotherapy. The potential toxicity of prolonged exposure to a single inducer might thus be mitigated by sequential brief exposures to different inducers.This publication has 22 references indexed in Scilit:
- 1α,25-Dihyroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytesBiochemical and Biophysical Research Communications, 1983
- Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea.Molecular and Cellular Biology, 1983
- SURFACE MARKER ANALYSIS OF ACUTE MYELOBLASTIC-LEUKEMIA - IDENTIFICATION OF DIFFERENTIATION-ASSOCIATED PHENOTYPES1983
- 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cellsLeukemia Research, 1983
- Expression of myeloid differentiation antigens on normal and malignant myeloid cells.Journal of Clinical Investigation, 1981
- Uncoupling lymphocyte proliferation from differentiation: Dissimilar dose-response relations for pokeweed mitogen-induced proliferation and differentiation of normal human lymphocytesCellular Immunology, 1981
- Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell lineProceedings of the National Academy of Sciences, 1981
- Polyclonal mitogenesis of human lymphocytes by PWM: Two preprogrammed division cycles resulting in cells refractile to further mitogenesisCellular Immunology, 1981
- TERMINAL DIFFERENTIATION SURFACE-ANTIGENS OF MYELOMONOCYTIC CELLS ARE EXPRESSED IN HUMAN PROMYELOCYTIC LEUKEMIA-CELLS (HL60) TREATED WITH CHEMICAL INDUCERS1981
- Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.Proceedings of the National Academy of Sciences, 1980